CompaniesPyxis Oncology

Pyxis Oncology

active

Boston, MA, United States

Founded 2019

About

Antibody Immunotherapy

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyBoston & New England

Team (20)

Anthony W. Tolcher, M.D., FRCPC, FACP

Christopher O’Donnell

Christopher O’Donnell, Ph.D.

Elliott Levy, M.D.

Freda Lewis-Hall

Freda Lewis-Hall, M.D.

Giulio Draetta, M.D., Ph.D.

View all 20 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

32

By Phase

PHASE1/PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT02706353Collaborator

APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma

PHASE1/PHASE2Active, not recruiting

32 participants

Started: Jun 2, 2017 · Completed: Apr 30, 2025

Funding History (20)

8-K

Aug 14, 2025

8-K

Aug 4, 2025

8-K

Jul 3, 2025

8-K

Jun 18, 2025

8-K

May 15, 2025

DEFA14A

Apr 29, 2025

DEF 14A

Apr 29, 2025

8-K

Mar 24, 2025

8-K

Mar 18, 2025

8-K

Feb 26, 2025

Locations (1)

Headquarters

Boston, MA, United States

Map

Loading map...